SLC25A21 and colorectal carcinoma: Mechanistic investigations revealed that SLC25A21 downregulation inhibited Gln-derived α-KG efflux and potentiated glutaminolysis to replenish the tricarboxylic acid (TCA) cycle, accompanied by an increase in GTP availability for persistent KRAS activation in KRAS-mutant CRC.